Indicate the long-acting topical decongestant agents:

Questions 52

ATI RN

ATI RN Test Bank

Drugs for Cardiovascular Disease Questions

Question 1 of 5

Indicate the long-acting topical decongestant agents:

Correct Answer: D

Rationale: Step 1: Long-acting decongestants are preferred for sustained relief. Step 2: Xylometazoline has a longer duration of action compared to other choices. Step 3: Epinephrine and norepinephrine are short-acting sympathomimetic agents. Step 4: Phenylephrine is intermediate-acting, not long-acting. Step 5: Therefore, D (Xylometazoline) is the correct choice for long-acting topical decongestant agents.

Question 2 of 5

The mechanism of action of antiseizure drugs is:

Correct Answer: D

Rationale: The correct answer is D. Antiseizure drugs work through multiple mechanisms to prevent seizures. 1. A: Antiseizure drugs enhance GABAergic transmission, increasing inhibition in the brain. 2. B: They also diminish excitatory glutamatergic transmission, reducing neuronal excitation. 3. C: Antiseizure drugs modify ionic conductance to stabilize neuronal activity. Therefore, the correct answer is D, as antiseizure drugs act through all the mentioned mechanisms to prevent seizures effectively. Choices A, B, and C are incorrect because they do not encompass the comprehensive range of mechanisms involved in the action of antiseizure drugs.

Question 3 of 5

Which of the following neurotransmitters is involved in Parkinson′s disease?

Correct Answer: C

Rationale: The correct answer is C: Dopamine. Parkinson's disease is characterized by a loss of dopamine-producing neurons in the brain. Dopamine is crucial for controlling movement and coordination, and its deficiency leads to symptoms of Parkinson's. Acetylcholine (Choice A) is not primarily involved in Parkinson's disease, and excess glutamate (Choice B) can actually be harmful in neurodegenerative disorders. Choice D is incorrect as acetylcholine and glutamate are not directly related to Parkinson's disease.

Question 4 of 5

Which of the following opioid analgesics is used in combination with droperidol in neuroleptanalgesia?

Correct Answer: C

Rationale: The correct answer is C: Fentanyl. Fentanyl is used in combination with droperidol in neuroleptanalgesia due to its fast onset of action and potent analgesic effects, making it an ideal choice for sedation and analgesia during procedures. Morphine (choice A) is not typically used in neuroleptanalgesia due to its slower onset of action and shorter duration. Buprenorphine (choice B) is a partial opioid agonist and is not commonly used in neuroleptanalgesia. Lastly, the duplicate choice D (Morphine) is incorrect for the same reasons mentioned earlier. In summary, Fentanyl is the preferred choice for neuroleptanalgesia due to its rapid onset and potent analgesic properties compared to the other options.

Question 5 of 5

Analgin usefulness is limited by:

Correct Answer: A

Rationale: The correct answer is A: Agranulocytosis. Analgin can cause a serious side effect called agranulocytosis, which is a condition where the bone marrow stops producing enough white blood cells, leaving the body vulnerable to infections. This limits the usefulness of Analgin as the risk of developing agranulocytosis outweighs its benefits. Summary of other choices: B: Erosions and gastric bleeding - While Analgin can cause gastrointestinal side effects like erosions and bleeding, these are not as severe or limiting as agranulocytosis. C: Methemoglobinemia - Although Analgin can lead to methemoglobinemia, it is a rare side effect compared to agranulocytosis. D: Hearing impairment - There is no significant evidence linking Analgin to hearing impairment, making this choice incorrect.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions